Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Dr. Martens Plc ( (GB:DOCS) ) just unveiled an announcement.
Dr. Martens plc has confirmed that, as of 31 December 2025, its issued ordinary share capital comprises 967,295,505 shares of GBP 0.01 each, all of which carry one voting right and none of which are held in treasury. This disclosure formalises the total number of voting shares in issue, providing investors with the denominator needed to assess and report significant shareholdings under UK transparency rules, and thereby supports regulatory compliance and clearer visibility over the company’s ownership structure.
The most recent analyst rating on (GB:DOCS) stock is a Hold with a £84.00 price target. To see the full list of analyst forecasts on Dr. Martens Plc stock, see the GB:DOCS Stock Forecast page.
Spark’s Take on GB:DOCS Stock
According to Spark, TipRanks’ AI Analyst, GB:DOCS is a Neutral.
Dr. Martens Plc’s overall stock score reflects a mix of financial challenges and strategic progress. The most significant factor is the company’s financial performance, which is hindered by declining revenue and profitability. Technical analysis indicates bearish momentum, while valuation suggests the stock is overvalued. Positive corporate events and earnings call insights provide some optimism, but challenges remain.
To see Spark’s full report on GB:DOCS stock, click here.
More about Dr. Martens Plc
Dr. Martens plc is a UK-listed footwear and apparel company best known for its iconic boots and shoes, operating within the global fashion and lifestyle sector and serving a broad consumer base through retail, wholesale and e-commerce channels.
Average Trading Volume: 1,136,487
Technical Sentiment Signal: Sell
Current Market Cap: £732M
Learn more about DOCS stock on TipRanks’ Stock Analysis page.